NARROWCLIFF SURGERY
NARROWCLIFF, NEWQUAY
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 96 | 117 | 82.1% | |
| CKD 4 | 2008 | 202 | 250 | 80.8% | |
| CKD 5 | 2009 | 10 | 11 | 90.9% | |
| CKD 5 | 2010 | 10 | 11 | 90.9% | |
| CKD 5 | 2011 | 8 | 10 | 80.0% | |
| CKD 5 | 2012 | 9 | 11 | 81.8% | |
| CKD 5 | 2013 | 8 | 10 | 80.0% | |
| CKD003 | 2014 | 8 | 8 | 100.0% | |
| CKD003 | 2015 | 10 | 11 | 90.9% | |
| NM84 | 2016 | 8 | 12 | 66.7% | |
| NM84 | 2017 | 8 | 11 | 72.7% | |
| NM84 | 2018 | 6 | 10 | 60.0% | |
| NM84 | 2019 | 4 | 9 | 44.4% | |
| NM84 | 2020 | 6 | 12 | 50.0% | |
| NM84 | 2022 | 10 | 13 | 76.9% |
